Live Nasdaq Composite: Cautious Optimism Takes Hold as Chip Stocks Rebound and SpaceX IPO Nears

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Douglas A. McIntyre | Jan 15, 2020 at 6:20 AM EST

Growing Number of Americans Still Don’t Think Vaccines Are Important

Some Americans believe that vaccinations are more dangerous than the diseases they prevent. The number is growing, says Gallup.

Chris Lange | Jan 14, 2020 at 12:10 PM EST

Will UnitedHealth Lift the Dow Again When It Reports Wednesday?

UnitedHealth is scheduled to report its most recent quarterly results before the opening bell on Wednesday.

Chris Lange | Jan 13, 2020 at 1:25 PM EST

Why Aquestive Therapeutics’ Seizure Treatment May Get Butted Out

Aquestive Therapeutics' shares lost nearly a third on Monday after the firm received an update from the FDA concerning its…

Chris Lange | Jan 13, 2020 at 10:55 AM EST

This T-Cell Therapy Could Be a Game Changer for Adaptimmune

Adaptimmune shares absolutely exploded on Monday after the company announced encouraging responses for its Spear T-cell platform.

Chris Lange | Jan 13, 2020 at 9:40 AM EST

Short Sellers Shy Away From Big Pharma

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 13, 2020 at 8:40 AM EST

Major Biotechs Have Short Sellers Excited

The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech…

Jon C. Ogg | Jan 11, 2020 at 7:05 AM EST

20 Biopharma Stocks for Huge Upside Potential in 2020

Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.

Chris Lange | Jan 10, 2020 at 10:05 AM EST

How This Dermira Acquisition Will Round Out Eli Lilly

Dermira shares made a handy gain to close out the week after it was announced that Eli Lilly would be…

Chris Lange | Jan 9, 2020 at 12:00 PM EST

How This Eye Study Is Making Waves

Applied Genetic Tech shares jumped by more than 50% on Thursday after the firm announced positive interim data from its…

Chris Lange | Jan 9, 2020 at 10:05 AM EST

Why This Peanut Allergy Study Was Worth the Wait

DBV Tech shares jumped on Thursday after the firm announced positive topline results from its late-stage study in children with…

Jon C. Ogg | Jan 7, 2020 at 2:58 PM EST

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.

Chris Lange | Jan 7, 2020 at 10:44 AM EST

Why This Study Is a Big Step Forward in the Fight Against Diabetes

Xeris Pharmaceuticals shares pushed higher on Tuesday after the firm announced positive topline results from its midstage study in adults…

Chris Lange | Jan 7, 2020 at 9:05 AM EST

Why This PNH Study Could Set the Standard for Treatment

Apellis Pharmaceuticals shares jumped on Tuesday after the firm announced positive results from its late stage study in adults with…

Chris Lange | Jan 3, 2020 at 11:15 AM EST

The Top Biotech ETFs to Watch in 2020

On a company by company basis, investing in biotechs is somewhat tricky. However, there is an investment strategy that makes…

Jon C. Ogg | Jan 2, 2020 at 4:51 PM EST

Is Pfizer Raising Drug Prices Too Much in 2020?

Ahead of election years, the cost and future of health care has become one of the top debates for better…

1 … 72 73 74 75 76 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Growing Number of Americans Still Don’t Think Vaccines Are Important

Will UnitedHealth Lift the Dow Again When It Reports Wednesday?

Why Aquestive Therapeutics’ Seizure Treatment May Get Butted Out

This T-Cell Therapy Could Be a Game Changer for Adaptimmune

Short Sellers Shy Away From Big Pharma

Major Biotechs Have Short Sellers Excited

20 Biopharma Stocks for Huge Upside Potential in 2020

How This Dermira Acquisition Will Round Out Eli Lilly

How This Eye Study Is Making Waves

Why This Peanut Allergy Study Was Worth the Wait

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

Why This Study Is a Big Step Forward in the Fight Against Diabetes

Why This PNH Study Could Set the Standard for Treatment

The Top Biotech ETFs to Watch in 2020

Is Pfizer Raising Drug Prices Too Much in 2020?

Live Nasdaq Composite: Cautious Optimism Takes Hold as Chip Stocks Rebound and SpaceX IPO Nears

Earning $0 or $100,000 in Your Final Year Barely Moves a 66-Year-Old’s Social Security, But It Can Raise Medicare Two Years Later

Dividend Safety Check: SNPD and a Portfolio of Dividend Stalwarts

Dividend Safety Check: International Small-Cap Value ETFs (DISV, ISVL)

Earning $0 or $100,000 in Your Final Year Barely Moves a 66-Year-Old's Social Security, But It Can Raise Medicare Two Years Later

COLA Went Up in 2026, but Medicare Quietly Took $215 of It

Earning $0 or $100,000 in Your Final Year Barely Moves a 66-Year-Old’s Social Security, But It Can Raise Medicare Two Years Later

Dividend Safety Check: SNPD and a Portfolio of Dividend Stalwarts

Health and Healthcare Articles

All Health and Healthcare Articles

Growing Number of Americans Still Don’t Think Vaccines Are Important

Will UnitedHealth Lift the Dow Again When It Reports Wednesday?

Why Aquestive Therapeutics’ Seizure Treatment May Get Butted Out

This T-Cell Therapy Could Be a Game Changer for Adaptimmune

Short Sellers Shy Away From Big Pharma

Major Biotechs Have Short Sellers Excited

20 Biopharma Stocks for Huge Upside Potential in 2020

How This Dermira Acquisition Will Round Out Eli Lilly

How This Eye Study Is Making Waves

Why This Peanut Allergy Study Was Worth the Wait

11 Biotech and Pharma Stocks With Huge Upside Targets for 2020

Why This Study Is a Big Step Forward in the Fight Against Diabetes

Why This PNH Study Could Set the Standard for Treatment

The Top Biotech ETFs to Watch in 2020

Is Pfizer Raising Drug Prices Too Much in 2020?

Live Nasdaq Composite: Cautious Optimism Takes Hold as Chip Stocks Rebound and SpaceX IPO Nears

Earning $0 or $100,000 in Your Final Year Barely Moves a 66-Year-Old’s Social Security, But It Can Raise Medicare Two Years Later

Dividend Safety Check: SNPD and a Portfolio of Dividend Stalwarts

Dividend Safety Check: International Small-Cap Value ETFs (DISV, ISVL)

Featured Reads

Earning $0 or $100,000 in Your Final Year Barely Moves a 66-Year-Old's Social Security, But It Can Raise Medicare Two Years Later

COLA Went Up in 2026, but Medicare Quietly Took $215 of It